New Medicines of 2015
Addyi is a prescription drug used to enhance sexual desire and decrease emotional distress in premenopausal women with hypoactive sexual desire disorder (HSDD). HSDD is the most commonly reported type of sexual dysfunction in women. Although Addyi has been called "the female Viagra,” the way it works is distinctly different from Viagra. Viagra works by increasing blood flow to the genitals, whereas Addyi works by correcting chemical imbalances in the brain to help restore sexual desire. Addyi comes in tablet form and is typically taken daily at bedtime. Common side effects include dizziness, nausea and sleepiness. Addyi can also cause fainting, especially when used with alcohol. Addyi is the first medication approved to treat sexual desire disorder in women.
Reviewed by:
Review Date:
December 29, 2015Citation:
U.S. Food and Drug Administration, "FDA approves first-of-its-kind product for the treatment of melanoma", 2015 U.S. Food and Drug Administration, "FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa", 2015 U.S. Food and Drug Administration, "FDA approves Ninlaro, new oral medication to treat multiple myeloma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for HIV", 2015 U.S. Food and Drug Administration, "FDA approves Nucala to treat severe asthma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for advanced pancreatic cancer", 2015 U.S. Food and Drug Administration, "FDA approves first treatment for sexual desire disorder", 2015 U.S. Food and Drug Administration, "FDA approves new drug to treat heart failure", 2015 U.S. Food and Drug Administration, "FDA approves Praluent to treat certain patients with high cholesterol", 2015 U.S. Food and Drug Administration, "FDA approves Corlanor to treat heart failure", 2015 All images appear courtesy of Dreamstime
Last Updated:
December 29, 2015